Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Comets

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Computer Methods and Programs in Biomedicine|February 26, 2018
dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trialsA Toumazi, E Comets, C Alberti, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations MembersF Mentré, M Chenel, E Comets, et al.
British Journal of Pharmacology|August 18, 2009
Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteersC Abbara, J M Rousseau, A Turcant, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patientsF Mentré, F Pousset, E Comets, et al.
British Journal of Clinical Pharmacology|August 23, 2007
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature surveyC Dartois, K Brendel, E Comets, et al.
Genes and Immunity|June 11, 2010
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signalingN Gestermann, A Mekinian, E Comets, et al.
Annals of the Rheumatic Diseases|August 4, 2007
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritisC Miceli-Richard, E Comets, C Verstuyft, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulationG Vlasakakis, E Comets, A Keunecke, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationaleN Grégoire, O Mimoz, B Mégarbane, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Computer Methods and Programs in Biomedicine|February 26, 2018
dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trialsA Toumazi, E Comets, C Alberti, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations MembersF Mentré, M Chenel, E Comets, et al.
British Journal of Pharmacology|August 18, 2009
Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteersC Abbara, J M Rousseau, A Turcant, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patientsF Mentré, F Pousset, E Comets, et al.
British Journal of Clinical Pharmacology|August 23, 2007
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature surveyC Dartois, K Brendel, E Comets, et al.
Genes and Immunity|June 11, 2010
STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signalingN Gestermann, A Mekinian, E Comets, et al.
Annals of the Rheumatic Diseases|August 4, 2007
A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritisC Miceli-Richard, E Comets, C Verstuyft, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulationG Vlasakakis, E Comets, A Keunecke, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationaleN Grégoire, O Mimoz, B Mégarbane, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.
Pageof 3